Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-23-001072
Filing Date
2023-02-13
Accepted
2023-02-13 12:04:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHI ADVISORS LLC lrmra2_21323.htm SC 13G/A 26409
  Complete submission text file 0001085146-23-001072.txt   28087
Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Subject) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88225 | Film No.: 23616021
SIC: 2834 Pharmaceutical Preparations

Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 2122014829
CHI Advisors LLC (Filed by) CIK: 0001791468 (see all company filings)

EIN.: 141874283 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G/A